Clinical Trial Update: Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating stereotactic radiosurgery with pembrolizumab for recurrent meningioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Nancy Ann Oberheim Bush, MD | Conditions: Grade I Meningioma, Adult, Grade II Meningioma, Adult | Phase 2 | Status: ACTIVE_NOT_RECRUITING